Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0ST5P
|
||||
Former ID |
DIB000411
|
||||
Drug Name |
TA-5538
|
||||
Synonyms |
IDDBCP232835
|
||||
Indication | Overactive bladder disorder [ICD9: 188, 596.51; ICD10:C67, N32.81] | Discontinued in Phase 2 | [548065] | ||
Company |
Tanabe Seiyaku Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
N1([C@H](C[C@H](CC1)OC(=O)NCCO)c1c(cc(cc1)F)C)C(=O)N(C)<br />Cc1cc(cc(c1)C(F)(F)F)C(F)(F)F
|
||||
Target and Pathway | |||||
Target(s) | Substance-P receptor | Target Info | Antagonist | [548066] | |
PANTHER Pathway | CCKR signaling map ST | ||||
Reactome | G alpha (q) signalling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.